Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients' Perspectives.
Journal: Breast care (Basel, Switzerland)
Published: June 10, 2025
Real-world clinical profile, RET mutation testing, treatments, and PROs for MTC in Europe.
Journal: European thyroid journal
Published: August 29, 2023
Real-world clinical profile, treatment patterns and patient-reported outcomes for thyroid cancer in Japan.
Journal: Future oncology (London, England)
Published: June 06, 2023
Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma.
Journal: Future oncology (London, England)
Published: November 15, 2022
BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel.
Journal: Cancers
Published: August 31, 2022
Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel.
Journal: Advances in therapy
Published: July 13, 2022
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel.
Journal: Breast (Edinburgh, Scotland)
Published: July 07, 2022
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel.
Journal: BMC cancer
Published: May 09, 2022
Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.
Journal: Future oncology (London, England)
Published: January 31, 2022
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries.
Journal: Breast care (Basel, Switzerland)
Published: October 06, 2021
Reliability, validity and important difference estimates for the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18).
Journal: Future oncology (London, England)
Published: July 21, 2021
Last Updated: 09/26/2026